These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 160510)
21. Role of T-cells in the mechanism of reactivity of the microplate leukocyte adherence inhibition assay. Raina S; Russo AJ; Jenkins D; Goldrosen MH Cancer Res; 1981 Oct; 41(10):3950-5. PubMed ID: 6456811 [TBL] [Abstract][Full Text] [Related]
22. Immunological activity of regional lymph nodes in tumor-bearing mice. Barna BP; Deodhar SD Cancer Res; 1979 Jul; 39(7 Pt 1):2711-7. PubMed ID: 312691 [TBL] [Abstract][Full Text] [Related]
23. [Suppressor mechanism in tumor immunology: characteristics of suppressor T-cells in glioma-bearing mice]. Yamasaki T; Yamashita J; Handa H; Namba Y; Hanaoka M No To Shinkei; 1983 Jul; 35(7):703-9. PubMed ID: 6194806 [TBL] [Abstract][Full Text] [Related]
24. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype. Lynch DH; Daynes RA; Hodes RJ J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117 [TBL] [Abstract][Full Text] [Related]
25. Characterization of immunosuppressor cells in rats immunized with solubilized tumor-associated antigens prepared from a methylcholanthrene-induced fibrosarcoma. Minami A; Kasai M; Mizushima Y; Takeichi N; Hosokawa M; Kobayashi H Cancer Res; 1980 Jul; 40(7):2129-34. PubMed ID: 6446378 [TBL] [Abstract][Full Text] [Related]
26. Effect of Propionibacterium acnes on the cellular immune responses to tumor-specific antigens on malignant rat liver cells. Yokota T; Katahira S; Konno K; Minami K J Natl Cancer Inst; 1979 Jun; 62(6):1511-5. PubMed ID: 86635 [TBL] [Abstract][Full Text] [Related]
27. The immunological basis of tumor rejection: the absolute dependence of the effector arm on sensitized T cells after chemoimmunotherapy of a murine sarcoma. Evans R; Duffy T J Immunol; 1985 Jun; 134(6):4255-60. PubMed ID: 3872913 [TBL] [Abstract][Full Text] [Related]
28. Regulation of the immune response to tumor antigens. II. The nature of immunosuppressor cells in tumor-bearing hosts. Fujimoto S; Greene MI; Sehon AH J Immunol; 1976 Mar; 116(3):800-6. PubMed ID: 1254955 [TBL] [Abstract][Full Text] [Related]
30. Chemical enhancement of tumor immunogenicity. Eggers AE; Hibbard CA; Civin CI; Wunderlich JR J Immunol; 1980 Oct; 125(4):1737-44. PubMed ID: 6967915 [TBL] [Abstract][Full Text] [Related]
31. Specific adoptive immunotherapy mediated by tumor-draining lymph node cells sequentially activated with anti-CD3 and IL-2. Yoshizawa H; Chang AE; Shu S J Immunol; 1991 Jul; 147(2):729-37. PubMed ID: 1830072 [TBL] [Abstract][Full Text] [Related]
32. Regeneration and the immune system. II. Suppressor activities of lymphocytes activated in vivo by liver regeneration and their genetic control. Yokomuro K; Miyahara S; Takahashi H; Kimura Y Eur J Immunol; 1983 Nov; 13(11):883-9. PubMed ID: 6227490 [TBL] [Abstract][Full Text] [Related]
33. Cross-reacting antigens in chemically induced sarcomas are fetal determinants. Parker GA; Rosenberg SA J Immunol; 1977 May; 118(5):1590-4. PubMed ID: 67142 [TBL] [Abstract][Full Text] [Related]
34. Nonspecific regulatory mechanism of contact sensitivity: nonspecific suppressor factor suppresses the antigen-presenting activity of dendritic cells to induce contact sensitivity. Nakano Y; Hori S; Ihara M Cell Immunol; 1994 Oct; 158(1):228-40. PubMed ID: 8087867 [TBL] [Abstract][Full Text] [Related]
35. T helper target cell DNA fragmentation through a CD4-positive T suppressor cell clone inducing specific unresponsiveness. Becker C; Konur A; Rademaekers A; Kodelja V; Partenheimer A; Pauels HG; Kölsch E Cell Immunol; 1994 Feb; 153(2):505-15. PubMed ID: 7907005 [TBL] [Abstract][Full Text] [Related]
36. Suppressor cells in the spleens of tumor-bearing mice: enrichment by centrifugation on hypaque-ficoll and characterization of the suppressor population. Pope BL; Whitney RB; Levy JG; Kilburn DG J Immunol; 1976 May; 116(5):1342-6. PubMed ID: 1270799 [TBL] [Abstract][Full Text] [Related]
37. Interaction of subpopulations of murine lymph node lymphocytes in antigen-induced [14C]-thymidine incorporation: T and B cell synergy in the response to antigen. Brummer E; Bhardwaj N; Lawrence HS Immunology; 1979 Oct; 38(2):301-10. PubMed ID: 389784 [TBL] [Abstract][Full Text] [Related]
38. A comparison of in vitro cell-mediated reactivity against syngeneic tumor cells by various lymphoid cell populations from Bacillus Calmette-Guérin-tumor-cured, tumor-sensitized, tumor-bearing, and normal inbred guinea pigs. Fidler IJ; Kataoka T; Hanna MG Cancer Res; 1976 Dec; 36(12):4459-66. PubMed ID: 187324 [TBL] [Abstract][Full Text] [Related]
39. Establishment and immunologic characterization of 3-methylcholanthrene-induced sarcoma cell lines metastasizing widely in mice and exhibiting distinct and selective propensities for the mode of metastasis. Kodama Y; Seyama T; Kamiya K; Yokoro K J Natl Cancer Inst; 1982 Sep; 69(3):595-605. PubMed ID: 7050499 [TBL] [Abstract][Full Text] [Related]
40. Characterization of a cloned ultraviolet radiation (UV)-induced suppressor T cell line that is capable of inhibiting anti-UV tumor-immune responses. Roberts LK J Immunol; 1986 Mar; 136(5):1908-16. PubMed ID: 2936813 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]